Oxfam reaction to US support of WTO TRIPS waiver on COVID vaccines

- Published:
- Short URL: https://www.oxfam.org.uk/mc/bmdy5v/

In response to today’s announcement that the US Trade Representative is supporting waiving intellectual property rights on COVID-19 vaccines, Oxfam’s Health Policy Manager, Anna Marriott, said:

“In this moment of crisis, we applaud the decision of President Biden and his administration to pursue a new path that prioritizes public health over private profits.

“This is a testament to the widespread public movement calling for an end to vaccine monopolies.

“We are at a crucial point in the fight against coronavirus, yet we have remained essentially at the mercy of a handful of giant pharmaceutical corporations that have monopoly control over the life-saving technologies we all need. The UK shouldn't be left standing on the wrong side of history and must join the US in doing the right thing for humanity.

“We will now look to the White House for leadership in a strong WTO outcome, in urgently insisting on the transfer of technologies through the World Health Organization Covid-19 Technology Access pool, and in investing strategically to build up regional vaccine hubs to defeat this and future pandemics.

“The horrific situation in India is a warning to all of us that if we don’t move urgently to share the vaccine technology and scale up manufacturing so everyone, everywhere can have access to these lifesaving vaccines, we will never get the upper hand on COVID anywhere.”


For more information or to arrange an interview please contact Sarah Dransfield in the Oxfam Press Office on: 07884 114825 or email sdransfield@oxfam.org.uk


Over the past year, nurses, doctors, Nobel Laureates, former heads of state, artists, economists, public health activists and more than two million people from around the world have rallied together to call for a People’s Vaccine.

Press contact

For comments, interviews, or information please contact Sarah Dransfield (Senior Press Officer):